Akari Therapeutics Plc (AKTX)

5.80 -0.20 (-3.33%) USD  |  NASDAQ  |  Apr 24, 16:00
5.80 0.00 (0.00%) After-Hours: 20:00
More

Akari Therapeutics EPS Diluted (Quarterly) : 0.00 for Dec. 31, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
DBV Technologies SA -1.170
Cellectis SA -0.2621
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc -0.0461
Evaxion AS -0.8933

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -5.290M
Total Expenses (Quarterly) 5.290M
Enterprise Value 2.130M
Earnings Yield -178.7%